Signal Explorer
10-K · 10-Q · 8-K · last 6 months · ← back to feed
Crinetics Pharmaceuticals, Inc.
CRNX
Other
Director Officer Indemnification Provision
Classified Board Director Election
Adjournment Proposal Voting Requirement
Stock Certificate Signature Requirement
Board Committee Member Listing
Corporate Organization And Standing Representation
Merger Subsidiary Creation
President Duties Defined
Quorum Adjournment Provision
Record Date Procedures Disclosed
Form 8K Filing Disclosure
Record Date Disclosure
Transfer And Demand Rights Limitations
Ltip Plan Title Citation
Employee Director Compensation Waiver
Other
Adjournment Proposal Voting Requirement
Other
Proxy Statement Mailing Date
Merger Proxy Statement Disclosure
Net Loss Reported
Other
Form 8K Filing Disclosure
Other
Cash Flow Statement Investing Activities
Net Loss Reported
Financing Activities Cash Flow Disclosure
Shares Outstanding Disclosure
Operating Lease Rent Expense Disclosed
Anti Takeover Provision Disclosure
Fast Track Designation Received
Fast Track Granted
Other Income Expense Disclosure
Breakthrough Therapy Granted
Shareholder Dilution Warning
Core
Regulatory Designation Only
Indication Expansion
Lead Asset Progress
Biotech v3
Ai Drug Discovery Investment
Other
Net Loss Reported
Fast Track Granted
Liquidity Position Snapshot Disclosed
Fast Track Designation Received
Orphan Status Granted
Breakthrough Therapy Granted
Rmat Designation Received
Healthcare
Reimbursement Improving
Volume Inflecting
Biotech Risk
Orphan Drug Designation
Accelerated Approval
Core
Indication Expansion
Lead Asset Progress
Regulatory Designation Only
SaaS
Membership Growing
Other
Non Solicitation Covenant
Other
Auditor Appointment Ratification
Quorum Presence Disclosed
Other
Segment Aggregation Disclosure
Ipo Net Proceeds Disclosure
Financing Activities Cash Flow Disclosure
Cash Flow Statement Investing Activities
Net Loss Reported
Forward Looking Statement Definition
Equity Plan Share Reserve Disclosure
Shares Outstanding Disclosure
Other Income Expense Disclosure
Codm Segment Reporting Disclosure
Capital Raising Uncertainty Disclosed
Core
Indication Expansion
Lead Asset Progress
Clinical Trial Result
Healthcare
Reimbursement Improving
Other
Net Loss Reported
Liquidity Position Snapshot Disclosed
Enrollment Ahead Of Schedule
Kol Endorsement
Healthcare
Reimbursement Improving
Volume Inflecting
Core
Patient Enrollment Velocity
Indication Expansion
Lead Asset Progress
Clinical Trial Result
Clinical Hold
SaaS
Usage Growth
Membership Growing
Same Client Revenue Growing
Biotech Risk
Crl Received
Other
Ip Assignment To Company
Confidential Information Definition
Non Assignment Clause
Termination For Material Breach Clause
Rsu Psu Vesting Schedule Disclosed
Power Of Attorney Disclosure
Arbitrator Selection Procedure
Core
Management Exodus